Top segments and regional performance

Last year, the company generated ‪811.00 M‬ CNY, the most of which — ‪780.87 M‬ CNY — came from its top-performing segment, Non-clinical Contract Research Organization, compared to ‪1.09 B‬ CNY the previous year. The greatest contribution came from China, which accounted for ‪761.52 M‬ CNY last year, with ‪1.12 B‬ CNY the year before.